Phase II study on lapatinib in advanced EGFR-positive chordoma.

Stacchiotti, S

Phase II study on lapatinib in advanced EGFR-positive chordoma. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Jul 2013 - 1931-1936 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1569-8041

10.1093/annonc/mdt117 doi


Adult
Aged
Antineoplastic Agents--administration & dosage
Bone Neoplasms--drug therapy
Chordoma--drug therapy
Disease-Free Survival
Drug Administration Schedule
ErbB Receptors--metabolism
Female
Humans
Lapatinib
Male
Middle Aged
Quinazolines--administration & dosage
Sacrum--pathology
Skull Base--pathology
Treatment Outcome